The corporation selected Oxford due to past performance in similar areas. Nobody had experience with the vaccine, as the virus was new, and up to this point, an mRNA vaccine had not been commercially developed in regions such as the United States. However, we had previously proven ourselves in onboarding resources, project oversight, and validation. Therefore, the client trusted us to provide quality resources quickly.
Oxford committed to working through the holidays, providing seven team leads that covered shifts 24/7. In all, we supplied our client with nearly 50 high-quality automation, verification, and process engineers. They performed troubleshooting and verification testing of a new automated filling line to successfully startup and double production capacity.